Pauli, G.; Chao, P.-H.; Qin, Z.; Böttger, R.; Lee, S.E.; Li, S.-D.
Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer. Pharmaceutics 2021, 13, 1696.
https://doi.org/10.3390/pharmaceutics13101696
AMA Style
Pauli G, Chao P-H, Qin Z, Böttger R, Lee SE, Li S-D.
Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer. Pharmaceutics. 2021; 13(10):1696.
https://doi.org/10.3390/pharmaceutics13101696
Chicago/Turabian Style
Pauli, Griffin, Po-Han Chao, Zhu Qin, Roland Böttger, Suen Ern Lee, and Shyh-Dar Li.
2021. "Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer" Pharmaceutics 13, no. 10: 1696.
https://doi.org/10.3390/pharmaceutics13101696
APA Style
Pauli, G., Chao, P.-H., Qin, Z., Böttger, R., Lee, S. E., & Li, S.-D.
(2021). Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer. Pharmaceutics, 13(10), 1696.
https://doi.org/10.3390/pharmaceutics13101696